Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Friederich, P. W.
space
  arrow  Prins, M. H.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Frequency of Pregnancy-Related Venous Thromboembolism in Anticoagulant Factor-Deficient Women: Implications for Prophylaxis

right arrow Philip W. Friederich, BSc; Bernd-Jan Sanson, BSc; Paolo Simioni, MD; Sandra Zanardi, MD; Menno V. Huisman, MD, PhD; Iris Kindt, MD; Paolo Prandoni, MD, PhD; Harry R. Buller, MD, PhD; Antonio Girolami, MD, PhD; and Martin H. Prins, MD, PhD

15 December 1996 | Volume 125 Issue 12 | Pages 955-960

Background: It has been reported that women with an inherited deficiency of antithrombin, protein C, or protein S have an increased risk for developing venous thromboembolic disease during pregnancy and the postpartum period. However, because the available data on risk are flawed, it is difficult to define a rational, efficacious, and safe policy about prophylaxis for venous thromboembolism in these women.

Objective: To determine the frequency of venous thromboembolism during pregnancy and the postpartum period in women with heritable deficiencies of anticoagulant factors.

Design: Retrospective cohort study.

Setting: University outpatient clinics in the Netherlands and Italy.

Participants: 129 otherwise asymptomatic female family members of patients with a history of venous thromboembolism and an established deficiency of antithrombin, protein C, or protein S.

Measurements: Medical history, with specific attention to episodes of venous thromboembolism and obstetric history, was taken. The anticoagulant factor status of the study participants was determined. If a patient had an episode of venous thromboembolism, subsequent pregnancies in that patient were not analyzed.

Results: Of the 129 women who participated in the study, 60 had anticoagulant factor deficiency and 69 did not. In the nondeficient group, 198 pregnancies occurred; 1 of these (0.5%) was complicated by an episode of venous thromboembolism during the postpartum period. In the deficient group, 169 pregnancies occurred; 7 of these (4.1%) were complicated by an episode of venous thromboembolism during the third trimester of pregnancy (2 pregnancies [1.2%]) and the postpartum period (5 pregnancies [3.0%]). The risk for venous thromboembolism was increased eightfold in deficient women compared with nondeficient women (hazard ratio, 8.0 [95% CI, 1.2 to 184]).

Conclusions: Anticoagulant factor-deficient women have an increased risk for venous thromboembolism during pregnancy and the postpartum period. Although data from an appropriate randomized clinical trial are lacking, the frequency of venous thromboembolism seen in deficient women might justify the use of anticoagulative prophylaxis during the third trimester of pregnancy and the postpartum period.


Related articles in Annals:

Editorials
Thromboembolic Disease and Pregnancy: Are All Women Equal?
Richard V. Lee
Annals 1996 125: 1001-1003. [Full Text]  



This article has been cited by other articles:


Home page
ChestHome page
S. M. Bates, I. A. Greer, I. Pabinger, S. Sofaer, and J. Hirsh
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 844S - 886S.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
L Merriman and M Greaves
Testing for thrombophilia: an evidence-based approach
Postgrad. Med. J., November 1, 2006; 82(973): 699 - 704.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
J. N. Quinones, D. N. James, D. M. Stamilio, K. L. Cleary, and G. A. Macones
Thromboprophylaxis After Cesarean Delivery: A Decision Analysis
Obstet. Gynecol., October 1, 2005; 106(4): 733 - 740.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. M. Bates, I. A. Greer, J. Hirsh, and J. S. Ginsberg
Use of Antithrombotic Agents During Pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 627S - 644S.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
M. T. Sartori, C. Danesin, G. Saggiorato, D. Tormene, P. Simioni, L. Spiezia, G. M. Patrassi, and A. Girolami
The PAI-I gene 4G/5G Polymorphism and Deep Vein Thrombosis in Patients with Inherited Thrombophilia
Clinical and Applied Thrombosis/Hemostasis, October 1, 2003; 9(4): 299 - 307.
[Abstract] [PDF]


Home page
Vasc MedHome page
S. R Deitcher and M. P. Gomes
Hypercoagulable state testing and malignancy screening following venous thromboembolic events
Vascular Medicine, February 1, 2003; 8(1): 33 - 46.
[Abstract] [PDF]


Home page
BloodHome page
S. M. Bates and J. S. Ginsberg
How we manage venous thromboembolism during pregnancy
Blood, November 15, 2002; 100(10): 3470 - 3478.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Kalafatis, P. Simioni, D. Tormene, D. O. Beck, S. Luni, and A. Girolami
Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations
Blood, May 13, 2002; 99(11): 3985 - 3992.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
K. A. Bauer
The Thrombophilias: Well-Defined Risk Factors with Uncertain Therapeutic Implications
Ann Intern Med, September 4, 2001; 135(5): 367 - 373.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
U. Seligsohn and A. Lubetsky
Genetic Susceptibility to Venous Thrombosis
N. Engl. J. Med., April 19, 2001; 344(16): 1222 - 1231.
[Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
M. T. Sartori, P. Simioni, G. M. Patrassi, P. Theodoridis, D. Tormene, and A. Girolami
State-of-the-Art-Review : Combined Heterozygous Plasminogen Deficiency and Factor V Leiden Defect in the Same Kindred
Clinical and Applied Thrombosis/Hemostasis, January 1, 2000; 6(1): 36 - 40.
[Abstract] [PDF]


Home page
BloodHome page
B.-J. Sanson, P. Simioni, D. Tormene, M. Moia, P. W. Friederich, M. V. Huisman, P. Prandoni, A. Bura, L. Rejto, P. Wells, et al.
The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort Study
Blood, December 1, 1999; 94(11): 3702 - 3706.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
M. T. Sartori, G. M. Patrassi, P. Theodoridis, C. Danesin, C. Abati, and A. Girolami
Familial Association of Hypoplasminogenemia and Heterozygous Factor V Deficiency
Clinical and Applied Thrombosis/Hemostasis, October 1, 1999; 5(4): 277 - 281.
[Abstract] [PDF]


Home page
Eur Heart JHome page
M. de Swiet
Review Article: Management of pulmonary embolus in pregnancy
Eur. Heart J., October 1, 1999; 20(19): 1378 - 1385.
[PDF]


Home page
JWatch Women's HealthHome page
Pregnancy, Anticoagulant Deficiency, and Thromboembolic Risk
Journal Watch Women's Health, February 1, 1997; 1997(201): 17 - 17.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1996 by the American College of Physicians.